NeoImmuneTech, Inc. (KOSDAQ:950220)

NeoImmuneTech Revenue

In the year 2025, NeoImmuneTech had annual revenue of 94.82M KRW, down -44.35%. NeoImmuneTech had revenue of 38.78M in the quarter ending December 31, 2025, with 1.40% growth.

• Revenue: 94.82M
• Revenue Growth: -44.35%
• P/S Ratio: 487.96
• Revenue / Employee: 1.82M
• Employees: 52
• Market Cap: 46.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	94.82M	-75.56M	-44.35%
Dec 31, 2024	170.38M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error